Patient-specific cell-mediated immunity against human acoustic neuroma extract

Lymphocytes from 8 patients with acoustic neuromas and 8 healthy control persons were exposed to acoustic neuroma extract. Indirect leukocyte migration agarose technique was applied for detection of leukocyte migration inhibition (LMI). The standard technique was additionally modified using a specific assay for release of human leukocyte migration inhibitory factor (LIF). Both the standard technique and the LIF-specific assay revealed a significant LMI exerted by lymphocytes from patients, as compared with control persons. The LIF-specific assay demonstrates that the LMI is an expression of cell-mediated immunity due to release of LIF. The immune reaction is raised against an unknown antigen in acoustic neuroma extract. Further studies must determine whether the immune reaction is specific for acoustic neuroma patients vis-a-vis patients with other tumours, especially other neuromas.